Mestranol
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
3-Methoxy-19-nor-17α-pregna-1,3,5(10)-trien-20-yn-17-ol | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601050 |
Legal status | ? |
Identifiers | |
CAS number | 72-33-3 |
ATC code | None |
PubChem | CID 6291 |
DrugBank | DB01357 |
ChemSpider | 6054 |
UNII | B2V233XGE7 |
KEGG | D00575 |
ChEBI | CHEBI:6784 |
ChEMBL | CHEMBL1201151 |
Synonyms | (8S,9S,13S,14S,17S)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol |
Chemical data | |
Formula | C21H26O2 |
Mol. mass | 310.43 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Mestranol is the 3-methyl ether of ethinylestradiol. It was the estrogen used in many of the first oral contraceptives.
It is a biologically inactive prodrug of ethinylestradiol to which it is demethylated in the liver with a conversion efficiency of 70% (50 µg of mestranol is pharmacokinetically bioequivalent to 35 µg of ethinylestradiol).[1]
References
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.